What is the Difference Between IL-2 and IL-15?

🆚 Go to Comparative Table 🆚

IL-2 and IL-15 are both cytokines that play critical roles in the immune system, but they have distinct functions and mechanisms of action. Some key differences between IL-2 and IL-15 include:

  1. Receptors: Both IL-2 and IL-15 have heterotrimeric receptors with a common cytokine receptor subunit, γc (also known as IL-2Rγ or CD132), and a shared beta subunit, IL-2/15Rβ (also known as CD122). However, they have unique alpha chains, IL-2Rα and IL-15Rα, respectively, which could contribute to their distinct physiological effects.
  2. Synthesis and Secretion: IL-2 is predominantly a secreted cytokine, while IL-15 is a membrane-associated molecule. IL-2 is produced by activated T cells, and its expression is regulated at the transcriptional level. In contrast, IL-15 expression is controlled by multiple negative regulatory elements, including a long 5' UTR containing IL-13 upstream AUGs, an unusually long signal peptide, and an inhibitory element in the C terminus of the IL-15 mature coding sequence or protein.
  3. Cellular Effects: IL-2 usually favors the rapid proliferation of short-lived effector cells, while IL-15 supports the maintenance of long-lived memory cells. IL-15 stimulates the persistence of memory phenotype CD8+ T cells, whereas IL-2 inhibits their expression.
  4. Different Signaling Kinetics: IL-2 binds as a soluble ligand, whereas IL-15 is thought to be presented in trans by the IL-15Rα subunit to β/γ subunits on responding cells. IL-2 signaling is sustained because IL-2 up-regulates the expression of its α subunit, which replenishes surface levels of high-affinity IL-2 receptors. In contrast, IL-15 signaling is relatively transient, and IL-15Rα chain expression is not maintained in the presence of IL-15.

These differences in receptors, synthesis, cellular effects, and signaling kinetics contribute to the distinct roles of IL-2 and IL-15 in the immune system and their potential applications in cancer immunotherapy and other therapeutic settings.

Comparative Table: IL-2 vs IL-15

IL-2 and IL-15 are both interleukins in the immune system that play crucial roles in regulating T and NK cell functions. They share common receptor components and the JAK/STAT signaling pathway. However, there are several differences between them:

Feature IL-2 IL-15
Production Mainly produced by activated CD4 Th1 cells Expressed in various tissues, including keratinocytes and nerve cells
Form Predominantly a secreted cytokine Membrane-associated molecule
Receptor Uses IL-2Rα and IL-2Rβ as receptor subunits Uses IL-15Rα and IL-2/15Rβ as receptor subunits
Function Stimulates activated T cell proliferation, generates cytotoxic effector T cells, and activates NK cells Shares similar functions with IL-2, but its signals do not overlap with IL-2 signals
roles in cancer therapy Used in the treatment of cancer Recent data suggest IL-2 and IL-15 differ in their ability to activate T and NK cells to resist various forms of immune suppression

Despite their similarities, IL-2 and IL-15 signals differ in magnitude, timing, and context. While IL-2 binds its receptor as a soluble molecule, IL-15 is presented by IL-15Rα in trans to neighboring cells. Their distinct physiological distribution and receptor usage contribute to their unique roles in the immune system and potential applications in cancer immunotherapy.